• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Human umbilical cord derived mesenchymal stem cells in peripheral nerve regeneration

    2020-05-07 12:01:16ChristineBojanicKendrickToBridgetZhangChristopherMakWasimKhan
    World Journal of Stem Cells 2020年4期
    關(guān)鍵詞:所帶科學(xué)合理閱讀課

    Christine Bojanic, Kendrick To, Bridget Zhang, Christopher Mak, Wasim S Khan

    Christine Bojanic, Department of Plastic and Reconstructive Surgery, Cambridge University Hospitals NHS Trust, Cambridge CB2 0QQ, United Kingdom

    Kendrick To, Wasim S Khan, Division of Trauma and Orthopaedic Surgery, Addenbrooke's Hospital, University of Cambridge, Cambridge CB2 0QQ, United Kingdom

    Bridget Zhang, Christopher Mak, School of Clinical Medicine, University of Cambridge,Cambridge CB2 0QQ, United Kingdom

    Abstract

    Key words: Umbilical cord; Mesenchymal stem cells; Transplantation; Peripheral nerve regeneration

    INTRODUCTION

    Peripheral nerve injuries can occur as a result of trauma or disease and can lead to significant morbidity including sensory loss, motor loss and chronic pain[1]. These injuries cause life-long disability in up to 2.8% of all trauma patients[2]. Damage to peripheral nerves most commonly occurs as a result of laceration, compression,ischaemia or traction[1]. As classified by Seddon in 1943, nerve injury can range from focal demyelination termed neurapraxia, to total nerve transection termed neurotmesis[3,4]. The mechanism of recovery post-injury occurs by either branching of collateral axons or by regeneration of the damaged neuron[4,5]. In order for full neuronal recovery to occur, Wallerian degeneration, axonal regeneration and endorgan reinnervation must take place. This is driven by an array of neurotropic factors[4]. However, recovery in function following peripheral nerve injury is hindered by complex pathological mechanisms such as poor nerve regeneration,neuromuscular atrophy, and end-plate degeneration which can lead to suboptimal neuron function[6-9].

    Traditionally, peripheral nerve injury can be managed conservatively or surgically with neurolysis, neural suturing, end-to-side neurorrhaphy and nerve autograft[10-12].Even with optimum surgical repair, most methods will attain partial but not full return of nerve function[10]. Certain peripheral nerve injuries, such as severe brachial plexus or long traction injuries remain inoperable[10]. Autografts have several disadvantages, including donor site morbidity, mismatch in nerve and graft size resulting in poor engraftment, and the potential for development of painful neuromas[11,13,14]. Alternative methods of treating peripheral nerve injuries may be through cell-based regenerative therapies[15].

    Transplantation of mesenchymal stem cells (MSCs), given their regenerative properties and highly proliferative capacity, has been proposed as a promising therapeutic option for peripheral nerve regeneration[16,17]. MSCs are plastic-adherent,undifferentiated, multipotent cells that can be harvested from numerous sites of the body including bone marrow, adipose tissue, dental pulp, amniotic fluid and umbilical cord[17-19]. MSCs from different tissue origins can have distinct cytokine expression profiles, and thus may enable different MSCs to be particularly suited to certain clinical applications[20,21]. Owing to low immunogenicity, MSCs may be transplanted allogenically with minimal consequence[22]. The particular mechanisms through which MSCs aid nerve repair have not yet been fully characterised. MSCs from various sources such as adipose tissue and bone marrow are able to differentiate into Schwann cells[23,24]. While somein vitroexperiments suggest that transplanted MSCs may be stimulated by peripheral nerves to differentiate into Schwann cells[25],alternative findings have instead shown that transplanted MSCs encourage endogenous cells to express regenerative phenotypes[26]. Increasingly, MCSs are believed to mediate their regenerative properties predominantly through paracrine effects[27,28]. Aside from acting through soluble factors[29], MSCs have also demonstrated the ability to secrete extracellular vesicles that contain bioactive components such as miRNA and cytokines[30]. Indeed, native Schwann cells have been shown to facilitate axonal regeneration following injury through secretion of exosomes that decrease GTPase RhoA activity[31]. Similarly, human MSCs may act to achieve the same result through exosomes by upregulation of the PI3 kinase and Akt signalling cascades[32].

    MSCs from umbilical cord are convenient to harvest from post-natal tissue in a non-invasive manner and possess a high capacity to expandex vivo[33]. They express low levels of HLA-DR compared to MSCs from other cell sources and therefore pose low risk of immunogenic complications following allogenic transplantation[34].Through sequential treatment with β-mercaptoethanol and various cytokines,umbilical cord derived MSCs (UCMSCs) can adopt a Schwann-like phenotype[35]. In addition, UCMSCs have been shown to possess greater paracrine effects than those of bone marrow-derived MSCs (BMMSC) and adipose-derived MSCs[17,29], and are able to potentiate axonal regeneration and peripheral nerve functional regeneration through these effects[11,17,29,36]. UCMSCs have been proposed to exert neuroprotective effects through secretion of Brain Derived Neurotrophic Factor (BDNF)[37], angiopoietin-2 and CXCL-16[38,39]. Other studies have suggested that they indirectly promote neurogenesis[40,41]. UCMSCs are also able to indirectly enhance expression of neurotransmitters such as BDNF and neurotrophin-3 (NTF3) which are postulated to aid neuro-regeneration[42,43].

    To date, there have been over 400 clinical trials that explore the use of MSCs in transplantation; UCMSCs follow BMMSCs as the second most commonly used cell source[44]. In this PRISMA systematic review, we analyse the evidence for the use of human UCMSCs in peripheral nerve regeneration by examiningin vivostudies.

    MATERIALS AND METHODS

    A literature search was performed from conception to September 2019 using PubMed,EMBASE and Web of Science. The following search terms were used:((((((((Mesenchymal stem cells) OR mesenchymal stem cell) OR MSC) OR MSCs) OR Mesenchymal stromal cell) OR Mesenchymal cell)) AND (((((Nerve) OR Peripheral nerve) OR Peripheral nerve injury) OR damaged nerve) OR nerve injury)) AND((((((repair) OR regeneration) OR regrowth) OR regenerate) OR renew) OR restore).We adhered to the recommendations as stipulated by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines[45].

    We included case series, case control, cohort studies and randomised controlled trials. We enrolled studies that examined peripheral nerve lesions treated with human UCMSCs inin vivohuman and animal subjects. Studies that only conductedin vitroexperiments were excluded. Studies that investigated central nervous system regeneration using UCMSCs were excluded. All included studies were published in the English language. We excluded all unpublished and retracted literature.

    CB and KT carried out the search independently. RoB2 tool was used by CM and BZ to assess the risk of bias in the studies, all discrepancy in results were resolved by discussion.

    RESULTS

    A total of 210 studies were screened for title, abstract and the inclusion/exclusion criteria were applied (Figure 1). One retracted study was excluded. Fourteen studies were reviewed in full text. The overall bias of studies is shown in Figure 2. The summary of results is shown in Figure 3. All 14 studies were of a case control design(Table 1). Four studies obtained UCMSCs from a third-party source and the remainder were harvested directly from human subjects. Out of the 14 studies, ten involved xenogenic transplantation into sciatic nerve injury specimens that were either crushed or transected. The studies were grouped according to Seddon’s seminal nerve injury classification system, which includes axonotmesis (injury to nerve sheath alone) and neurotmesis (injury to the entire nerve)[3]. A total of 279 subjects were treated with UCMSCs. All studies reported significant improvement in UCMSC treated groups compared with the various different controls and untreated groups.

    The studies did not report any significant complications.

    UCMSCs in peripheral nerve axonotmesis

    Four studies that included a total of 90 treated subjects assessed the use of UCMSCs in peripheral nerve axonotmesis models of sciatic nerve crush injury (Table 1). All four studies harvested UCMSCs from human subjects and transplanted the UCMSCs into murine subjects. The methods of UCMSC delivery to the crush injury varied among studies.

    Studies, by Sunget al[46](2012) and Heiet al[47](2016) examined the effect of direct intralesional UCMSC injections on murine subjects with sciatic nerve crush injuries.Both studies monitored subjects up to 4 wk post-intervention. Sunget al[46](2012)found that expression of brain-derived neurotrophic factor (BDNF) and tyrosine kinase receptor B mRNA increased at 4 wk following UCMSC injection. Functional recovery was measured in terms of the sciatic function index (SFI), which showed a dramatic improvement at 4 wk in UCMSC treated groups compared to untreated groups. Retrograde axonal transport was estimated through fluoro Gold-labelled neuron counts and the UCMSC group was found to have a significantly higher neuron count. It was found that axon density was significantly greater in the UCMSC group. Heiet al[47](2016) transfected UCMSCs with a BDNF-adenovirus vector. The authors found that both UCMSC and BDNF-UCMSC groups had significant improvements in SFI, axon count and axon density at 4 wk after treatment. The BDNF-UCMSC group displayed increased peripheral nerve regeneration compared with UCMSC alone.

    Gartneret al[48,49]conducted two studies published in the same year. In one study,Chitosan type III membrane was used to aid UCMSC infiltration in murine sciatic crush models[48]. The authors evaluated motor and sensory functional recovery up to 12 wk following transplantation with and without Chitosan type III wrapping. Both treatment groups showed improvement in SFI, extensor postural thrust (EPT) and withdrawal reflex latency (WRL). The control group with Chitosan type III membrane alone showed a significant improvement in post-traumatic axonal regrowth compared to the untreated control group. In a separate study, the same group examined the effect of using poly (DL-lactide-e-caprolactone) (PLC) membranes to deliver UCMSCs into sciatic nerve crush injuries[49]. Peripheral nerve regeneration was assessed in terms of SFI, EPT, and WRL at 12 wk. Undifferentiated and differentiated UCMSCs were used in different groups. Both groups showed an increase in myelin sheath thickness compared to control groups. The SFI was severely affected at week-2 postcrush injury in all experimental groups and improved gradually up to week 12 when values were indistinguishable from controls.

    Studies of UCMSCs in peripheral nerve neurotmesis

    Nine of the fourteen studies assessed the use of UCMSCs in peripheral nerve neurotmesis models (Table 2). All nine were case control studies. Five studies had murine subjects, two had rabbit subjects, one had canine subjects, and one had human subjects. Six studies transplanted UCMSCs into a sciatic nerve gap model. Two studies transplanted UCMSCs into tibial nerve and recurrent laryngeal nerve crush models. One study conducted allogenic transplantation in humans. A total of 151 subjects were treated. Methods of MSC delivery and transplantation varied among studies.

    Several groups sought to improve nerve regeneration with UCMSCs combined with longitudinal scaffolds. Zarbakhshet al[11](2015) loaded UCMSCs on a silicone tube and interposed it into a murine sciatic nerve gap model. The authors attempted to compare the histological outcomes of human UCMSCs and rat BMMSCs in regenerating sciatic nerve gap in rats. While the author showed favourable results in nerve regeneration for both UCMSCs and BMMSC, the latter was found to produce superior results at the end point of 12 wk. The BMMSC group showed greater axon number and thicker myelin sheath diameter than the UCMSC group.

    Maet al[17](2019) injected UCMSC-derived extracellular vesicles (EVs) into the tail veins of rats and sutured a silicone rubber tube into the sciatic nerve gaps of 24 rats.The authors found that UCMSC-EVs promoted motor function recovery and regeneration of axons and attenuated muscle atrophy. SFI analysis was used to assess the functional improvements. At 8 wk, UCMSC-EV group had similar SFI values to normal rats.

    總之,幾種教學(xué)方法,只有根據(jù)小學(xué)語文閱讀課的教材實(shí)際,根據(jù)所帶學(xué)生的認(rèn)知特點(diǎn),進(jìn)行有主有次,科學(xué)合理的組織,綜合的運(yùn)用,才能收到卓越的功效。

    Matsuseet al[35](2010) combined UCMSCs and Matrigel into transpermeable tubes and transplanted it into transected murine sciatic nerve tissue specimens. The authors induced UCMSCs into cells with Schwann cell properties by using βmercaptoethanol, all-trans-retinoic acid and various cytokines. Subsequently, Matsuseet al[35]examined the effect of these induced UCMSCs and used two control groups; a positive control of human Schwann cells and a negative control of Matrigel alone. Thegroup assessed SFI values and compared immunoelectron micrographs. They concluded that the treatment group with Schwann Cell-UCMSCs group was equivalent to treatment with Schwann cells based on histological criteria and functional recovery.

    Table 1 Studies of umbilical cord derived mesenchymal stem cells in peripheral nerve axonotmesis and diabetic neuropathy in vivo

    UCMSCs: Umbilical cord derived mesenchymal stem cells; BDNF: Brain-derived neurotrophic factor; SFI: Sciatic function index; PBS: Phosphate buffered saline; PLC: Poly (DL-lactide-ε-caprolactone); WRL: Withdrawal reflex latency; EPT: Extensor postural thrust.

    Cuiet al[14](2018) and Panet al[50](2017) delivered UCMSCs using a collagen conduit. Cuiet al[14](2018) transplanted human UCMSCs into canine sciatic nerve gap models via a longitudinally orientated collagen conduit embedded with UCMSCs.Compound muscle action potential (CMAP) was found to be statistically greater in the UCMSC treated group compared with the collagen conduit only group. Panet al[50](2017) appraised the use of UCMSCs with a heparinised collagen conduits in transected rabbit recurrent laryngeal nerves. The authors assessed the effectiveness of passage-4 UCMSCs loaded on heparinised scaffold that released Nerve growth factor(NGF). Electromyograms at 8 wk revealed that treated lesions recovered normal nerve function. Biological markers of neurogenesis, including calcium-binding protein S100,neurofilament and AChE, were expressed at a greater level following treatment. Xiaoet al[51](2015) undertook a study exploring the effect of UCMSCs in a chitosan conduit interposed into the tibial nerve of a rabbit model. Xiaoet al[51]found that nerve conduction velocity was significantly higher in the treatment group. The myelin sheath thickness and the growth of axis bud were both increased in the UCMSC group. Pereiraet al[52](2014) used PLC as a conduit for UCMSCs in murine sciatic nerve crush models. The group compared differentiated and undifferentiated UCMSCs. They established no difference in the degree of nerve regeneration between UCMSC that were differentiated into neural-glial-like cells and undifferentiated UCMSC groups. Both UCMSC groups showed increased myelin sheath thickness and enhanced recovery in motor and sensory function.

    Two groups sought to investigate the use of UCMSCs embedded on a human amniotic membrane scaffold[5,53]. Liet al[53](2012) found significant improvements in SFI, CMAP and gastrocnemius muscle diameter in UCMSC-loaded scaffolds group compared to cell-free scaffolds. Liet al[6](2013) analysed how UCMSCs loaded on a human amniotic membrane scaffold affected the repair of a transected radial nerve in human subjects. Thirty-two patients with radial nerve injuries from radial shaft fractures were included in the study; twelve patients received neurolysis to remove neural scar tissue, and transplantation of UCMSCs on an amniotic membrane. The remainder 18 patients received neurolysis only. At 12 wk, the electrophysiological function of the UCMSC-treated group had improved electromyography readings. The muscular power, touch sensation and pain sensation were also significantly improved as compared to the neurolysis group.

    Studies of UCMSCs in diabetic neuropathy

    Figure 1 PRlSMA Flow diagram.

    One study explored the role of UCMSCs in femoral nerve neuropathy[54](Table 1). The authors modelled diabetic neuropathy in murine subjects by inducing diabetes with streptozotocin and created a dorsal hind foot ulcer through empyrosis. UCMSCs were delivered intravascularly through the femoral artery in the treatment group. Saline injections were used in the control group. Serum NGF and neurofilament 200 (NF-200) were measured by Enzyme Linked Immunosorbent Assay (ELISA). The results demonstrated that serum NGF and NF-200 increased in the UCMSC treated rats.Additionally, functional studies using electroneurogram showed that femoral nerve conduction was improved in the UCMSC subjects.

    DISCUSSION

    The studies in this review reported compelling positive outcomes for the use of human UCMSC to repair peripheral nerve lesions. None of the studies reported immunogenic nor significant complications. While the source cell utilised was consistent among the studies, there were significant variability in cell treatment and methods of transplantation with variable effectiveness as determined by several different outcome measures. There was also moderate heterogeneity in thein vivomodels used. It is therefore difficult to draw conclusions on the optimal method of cell delivery to nerve lesions. Nevertheless, it does imply that UCMSCs are a useful cell source.

    The process of cell harvest did not vary greatly between the studies. Human umbilical cord and umbilical cord blood are generally considered medical waste and so there are minimal ethical barriers to tissue sampling[55]. This provides a practical advantage for the use of UCMSCs and may explain why it is commonly used in tissue engineering experiments. The biochemical properties of UCMSCs may also be of advantage as studies comparing different source cells for MSCs have found UCMSCs to possess a greater ability to proliferateex vivoand express a higher level of Vascular Endothelial Growth Factor (VEG-F) and Human Growth Factor (HGF) at late passages[56,57]. One study in this review compared UCMSCs to BMMSCs in sciatic nerve regeneration and found BMMSCs to produce superior results. The authors however, evaluated cell architecture on microscopy but did not carry out nerve conduction studies or functional analysis which may better inform clinical relevance[11]. UCMSCs also appear to have a different multilineage differentiation profiles to other MSC, and is able to be induced into neuron-like cellsin vitro, which may favour applications in nerve regeneration[58]. There is some evidence to suggest that characteristics of the donor affect the ability of UCMSCs to differentiate. For example, undifferentiated UCMSCs obtained from patients with pre-eclampsia may produce greater levels of neuronal markers[59]. Therefore, exploration of different patient and gestational characteristics, such as age could help determine optimal source conditions.

    Figure 2 Summary of overall bias.

    There is no set protocol for theex vivoexpansion of UCMSCs in the literature. In our article, UCMSCs were generally transplanted between the third and fifth passage.Indeed, the gene expression profile of UCMSC is known to vary according to the number of passages, with some studies showing that UCMSCs do not express CD105,a defining marker for MSCs, until passage-5[60]. In view of this, it would be meaningful to identify and investigate the expression of important neurogenic markers as a function of stages of passage in future experiments. Some of the studies in this review pre-treated UCMSCs in order to induce them into particular cellular phenotypes prior to transplantation. Pereiraet al[52]and Gartneret al[49]utilised a similar culture protocol and pre-treated UCMSCs with neurogenic media. They observed a neuroglial-like morphology on microscopy and a transcriptomic profile showing upregulation of neuroglial genes including Glial Fibrillary Acidic Protein (GFAP), Growth Associated Protein 43 (GAP43) and Neuronal Specific Nuclear Protein (NeuN). Both studies found differentiated MSCs to be more effective than undifferentiated UCMSCs. Aside from gene expression, it would be important to clarify the exact mechanism through which these differentiated cells act to promote nerve regeneration. The optimal protocol for differentiation is also ill-defined as Matsuseet al[35]used a different set of culture condition to induce UCMSCs into Schwann-like cells and found the latter to be more effective. Furthermore, there is a lack of agreement on the primary mode of action of MSCs in promoting nerve regeneration. It is unclear whether transplanted cells directly replicate and replace cells in the lesion. Some experiments of optic nerve lesions suggest that transplanted MSCs remain local and replicate[61]. Emergingin vitroevidence points towards paracrine effects as the predominant mechanism of action. It appears that pre-treatment of Schwann cells with UCMSC conditioned media increases BDNF and NGF expression which are surrogate measures of neurogenic potential[29]. In our review, Maket al[17]examined the effectiveness of UCMSC-derived exosomes in nerve repair. Through peripheral intravenous injection of UCMSC EVs,they demonstrated that it could act systemically to encourage nerve regeneration at a nerve gap without off-site complications. As the use of EVs in this endeavour gains attention, further studies would be required to establish a dose-response relationship and the best method for delivering EVs to lesions.

    Figure 3 Risk of bias in individual studies.

    It is difficult to determine the best UCMSC implantation method. Our review has captured studies that directly implanted UCMSCs and reported good outcomes.Studies investigating the use of conduits to guide nerve regeneration suggest that this is superior to direct implantation of MSCs alone[14,50]. The use of conduit that elude growth factors such as NGF along with UCMSC implantation appear to confer additional benefit[50]. Additionally, intravenous injection of UCMSC-EVs at a peripheral site also produce positive outcomes[17]. Interestingly, a comparison of local and intravenous BMMSC administration in sciatic nerve injury models suggest that systemic treatment provides a more significant improvement in nerve conduction,whereas local treatment improved neuronal fibre counts[62]. Other experiments have shown that peripherally injected MSCs localise to nerve lesions in murine models of sciatic nerve injury[63]. It could be inferred from these findings that there are differing mechanisms and sites of action for the two methods of implantation, suggesting that a treatment regime including both delivery methods concomitantly may produce the best outcome.

    There are several issues pertaining to translating the findings derived fromin vivoanimal models for therapeutic application in humans. The majority of studies in our review employed a murine surgical sciatic nerve defect model to assess nerve regeneration. The critical nerve gap length, defined as a gap across which regeneration would not occur without nerve grafting or bridging is considered to be greater in humans than murine subjects[64,65]. Therefore, studies assessing murine nerve gaps may overestimate the therapeutic potential of treatments. Furthermore, it may be difficult to scale-up effective concentrations of transplanted UCMSCs to humans. In a study of rat nerve defects treated with tacrolimus, functional recovery tapers off at 9 wk following treatment and becomes indistinguishable from untreated rats at 10 wk[66]. Therefore, at later time points, which are more relevant to clinical presentations of nerve injury, the regenerative biology of murine nerve appears to differ from that of humans. Our interpretation from thein vivoanimal studies in this review is complicated by the use of the sciatic nerve, which possesses a sensory and motor component, and thus renders functional analysis difficult. It is conceivable for sensory loss to mask a post-surgical motor defect on gait analysis, similarly, it may be possible for loss in motor function to cause underestimation of sensory recovery.Owing to the heterogeneity in starting points for different functional measures, a pooled analysis of quantitative outcomes could not be performed in this review.Therefore, clinically relevant and robust quantifiable outcome measures remain a significant barrier to the reliability of animal studies. One study in this review assessed UCMSC transplantation in human radial nerve defects and reported improved motor and sensory function and electrophysiological measures[53]. The group however, delivered the MSCs through a scaffold, and did not compare outcomes with a control group of the scaffold alone.

    According to the results of our risk of bias analysis, 13 of 14 studies had a moderate risk of bias, and one study had a high risk of bias (Figure 1). The reporting of outcome measures contributed to an increased risk of bias in all studies, as most of the studies reported improvement in some but not all outcomes yet concluded that UCMSCs were effective overall. This could be owing to the significant heterogeneity in cell treatment and delivery methods which as the literature suggests, could contribute to different aspects of nerve regeneration.

    Table 2 Studies of umbilical cord derived mesenchymal stem cells in Peripheral Nerve Neurotmesis in vivo

    Li et al[53],2012 Case Control Human Murine 40 amnion tube with UCMSCs 40 amnion tube with saline implant Human umbilical cords obtained from fullterm deliveries Passage 3-4 UCMSCs were cultured and loaded on an amniotic scaffold Xenogenic transplantati on into transected sciatic nerve tissue specimens 20 Significant improvement in SFI and CMAP in UCMSC group compared to control.Gradual improvement in threshold stimulus and maximum stimulus intensity in UCMSC group compared to control Li et al[6],2013 Case Control Human Human 12 neurolysis followed by 10 mL UCMSCs injection of 1.75 × 107 cells 20 neurolysis only Human umbilical cords obtained from fullterm deliveries Passage 2 UCMSCs were loaded on an amniotic membrane scaffold.Both groups received 3 days of oral cephalosporin Allogenic transplantati on into radial nerve injury following radial shaft fracture 12 Significant improvement in muscular strength,touch and pain sensations in UCMSC group compared to control.Improved electrophysiologica l function in UCMSC group as compared to control Matsuse et al[35], 2010 Case Control Human Murine 6 UCMSCs;10 Induced UCMSC 6 negative control; 5 induced UCMSC Wharton’s Jelly extracted from umbilical cords of fullterm caesarean deliveries Passage 3 UCMSCs were induced into Schwannlike cells Xenogenic transplantation into transected sciatic nerve tissue specimens 3 Significant improvement in SFI in all treated as compared to control with the greatest improvement in UCMSC group Xiao et al[51],2015 Case Control Human Rabbit 10 chitosan conduit anastomosis bridge filled with UCMSCs 10 chitosan conduit anastomosis only; 10 untreated Not specified UCMSCs were loaded into a chitosan conduit Xenogenic transplantati on into tibialcommon peroneal nerve endto-side anastomosis 12 Significant improvement in myelin sheath thickness,Schwann cell growth,growth of axis bud and growth velocity of regenerated fibre in UCMSC group compared to controls. No significant difference observed between either control groups

    UCMSCs: Umbilical cord derived mesenchymal stem cells; LOCC: Longitudinally orientated collagen conduit; SFI: Sciatic function index; NGF: Nerve growth factor; PBS: Phosphate buffered saline; HC: Heparinized collagen; PLC: Poly (DL-lactide-ε-caprolactone); EV: Extracellular vesicle.

    In conclusion, while there are homeostatic responses that promote nerve regeneration following injury, the body’s natural capacity is inadequate for the recovery of satisfactory nerve function. The evidence summarised in this systematic review supports the notion that UCMSC transplantation is an effective treatment option for nerve injury. Several barriers must be overcome before these findings can be translated into the clinical setting. Importantly, development of a reliablein vivoanimal model, and a standardised method of assessing nerve regeneration would allow the optimal method of cell transplantation to be determined.

    ARTICLE HIGHLIGHTS

    Research background

    Peripheral nerve injury can be a debilitating condition. Traditional treatment options are often ineffective. There is an urgent need for new treatment modalities. Mesenchymal stem cell (MSC)transplantation holds promise as a cell-based regenerative approach in treating nerve lesions.MSCs can be sourced from various tissues, and this may affect their regenerative capacity. Here,we appraise thein vivoevidence for the use of human umbilical cord-derived MSCs (UCMSCs)in peripheral nerve regeneration.

    Research motivation

    There is contention regarding the optimal cell-source for the harvest of MSCs. Some evidence suggests that MSCs from certain tissue types have superior neurogenic capacity. It is critical that we determine the best cell-source for nerve repair, in order to facilitate an efficient production protocol and maximise clinical benefit.

    Research objectives

    To investigate whether UCMSCs are effective in nerve regeneration inin vivomodels of nerve injury.

    Research methods

    We performed a systematic literature review according to the PRISMA statement. A search was conducted on three databases (PubMed, EMBASE and Web of Science) by two independent investigators from inception to September 2019 for studies examining the use of UCMSCs inin vivomodels of nerve injury. The evidence was appraised using Cochrane’s RoB 2.0 Tool.

    Research results

    A total of 14 studies were included in the review, with a total of 279 subjects. The studies reported that transplantation of human umbilical cord MSCs were effective in regenerating nerve lesions. There were general improvements in histological and functional outcomes. The studies did not report significant complications.

    Research conclusions

    Human umbilical cord-derived MSCs were effective in repairing nerve lesions in both animal and human models of nerve injury. Additional studies are required to correlate histological outcomes with functional improvements, as not all studies assessed both. More human studies are necessary to inform the efficacy in humans. High quality randomized controlled trials would be instructive in this case. Long-term follow up in these types of study will help inform the safety of MSC transplantation.

    Research perspectives

    There is limited evidence examining the use of MSCs derived from other tissues in their capacity to regenerate nerve lesions. Further studies comparing different tissue cell-source directly would be highly informative.In vitrostudies of MSC-biomaterial scaffolds may aid the development of more efficient MSC delivery methods. As the nature of nerve injury can vary significantly, the approach to transplantation, such as dose delivery may need to be catered to the individual lesion. Studies comparing the effect of MSCs on differentin vivomodels could help delineate this.

    猜你喜歡
    所帶科學(xué)合理閱讀課
    基于主題意義的“生本”高中英語閱讀課
    初中英語閱讀課有效詞匯教學(xué)策略
    深山狩獵
    薪酬管理在企業(yè)人才激勵中發(fā)揮的作用
    淺談小學(xué)語文高年級課前預(yù)習(xí)有效指導(dǎo)的研究
    速讀·中旬(2017年3期)2017-05-06 08:18:53
    生活化教學(xué)法在小學(xué)科學(xué)教育中的作用
    “電流和電路”“電壓電阻”易錯題練習(xí)
    合作學(xué)習(xí)在大學(xué)德語閱讀課中的應(yīng)用
    實(shí)現(xiàn)小學(xué)數(shù)學(xué)課堂教學(xué)的高效性
    AneCan戀愛觀大調(diào)查!
    秀·媛尚(2013年6期)2013-09-12 03:17:06
    2022亚洲国产成人精品| 国产极品天堂在线| 制服丝袜香蕉在线| 丰满人妻一区二区三区视频av| 亚洲第一区二区三区不卡| 精品国产露脸久久av麻豆| 大陆偷拍与自拍| 肉色欧美久久久久久久蜜桃| 日本av免费视频播放| 亚洲熟女精品中文字幕| 一级毛片 在线播放| 久久久国产一区二区| 欧美少妇被猛烈插入视频| 亚洲av国产av综合av卡| 一区二区三区精品91| 日韩av在线免费看完整版不卡| 成人高潮视频无遮挡免费网站| 久久精品熟女亚洲av麻豆精品| av在线老鸭窝| 欧美日本视频| 熟女电影av网| 国产高潮美女av| 国产成人91sexporn| 在线观看三级黄色| 深爱激情五月婷婷| 亚洲婷婷狠狠爱综合网| 免费黄网站久久成人精品| 久久久a久久爽久久v久久| 另类亚洲欧美激情| 国产精品一区二区三区四区免费观看| 观看av在线不卡| 最近最新中文字幕免费大全7| 国产亚洲午夜精品一区二区久久| 综合色丁香网| 嘟嘟电影网在线观看| 亚洲精品一区蜜桃| 人人妻人人爽人人添夜夜欢视频 | 久久韩国三级中文字幕| 久久人人爽人人片av| 丝瓜视频免费看黄片| h视频一区二区三区| 熟妇人妻不卡中文字幕| h日本视频在线播放| 日韩欧美 国产精品| 深夜a级毛片| 黑人猛操日本美女一级片| 一区二区三区四区激情视频| 黄色视频在线播放观看不卡| 亚洲av在线观看美女高潮| 黄色配什么色好看| 亚洲激情五月婷婷啪啪| 美女主播在线视频| 久久久久久久精品精品| 欧美精品亚洲一区二区| 国产欧美日韩精品一区二区| 国产精品久久久久久久电影| 欧美日韩精品成人综合77777| 成人国产麻豆网| 卡戴珊不雅视频在线播放| 亚洲国产精品成人久久小说| 亚洲国产精品国产精品| 免费观看av网站的网址| 九九久久精品国产亚洲av麻豆| 欧美精品国产亚洲| 亚洲人与动物交配视频| 国产亚洲av片在线观看秒播厂| 精品视频人人做人人爽| 亚洲av国产av综合av卡| 国产国拍精品亚洲av在线观看| 久久 成人 亚洲| 特大巨黑吊av在线直播| 人妻一区二区av| 一级毛片黄色毛片免费观看视频| xxx大片免费视频| 精品少妇久久久久久888优播| 一级毛片我不卡| 极品少妇高潮喷水抽搐| 亚洲国产日韩一区二区| 日产精品乱码卡一卡2卡三| 91久久精品国产一区二区三区| 亚洲高清免费不卡视频| 超碰97精品在线观看| 国产伦在线观看视频一区| 熟女电影av网| 国产在线男女| 老师上课跳d突然被开到最大视频| 久久久午夜欧美精品| 欧美激情极品国产一区二区三区 | 中文字幕制服av| 国产精品欧美亚洲77777| 免费观看a级毛片全部| 两个人的视频大全免费| 伦精品一区二区三区| 老熟女久久久| 国产成人aa在线观看| 在线观看国产h片| 99久久中文字幕三级久久日本| 午夜福利在线在线| 少妇高潮的动态图| 亚洲人成网站在线观看播放| 中文资源天堂在线| 欧美日韩精品成人综合77777| 亚洲欧洲日产国产| 亚洲婷婷狠狠爱综合网| 熟妇人妻不卡中文字幕| 成人高潮视频无遮挡免费网站| 哪个播放器可以免费观看大片| 黑人猛操日本美女一级片| 午夜福利影视在线免费观看| 国产成人午夜福利电影在线观看| 亚洲精品乱码久久久久久按摩| 日韩av不卡免费在线播放| 99热国产这里只有精品6| 日韩一本色道免费dvd| 国产在线男女| 久久国产精品男人的天堂亚洲 | 视频中文字幕在线观看| 国产精品欧美亚洲77777| 免费久久久久久久精品成人欧美视频 | 亚洲av.av天堂| 午夜福利网站1000一区二区三区| 亚洲av日韩在线播放| 肉色欧美久久久久久久蜜桃| 免费观看a级毛片全部| 国产精品av视频在线免费观看| 丰满少妇做爰视频| 伊人久久国产一区二区| 高清午夜精品一区二区三区| 中文欧美无线码| 日韩成人av中文字幕在线观看| av不卡在线播放| 在线观看国产h片| 亚洲欧美成人精品一区二区| 亚洲不卡免费看| 欧美3d第一页| 91在线精品国自产拍蜜月| 18禁在线播放成人免费| 综合色丁香网| 美女福利国产在线 | 男女国产视频网站| 色哟哟·www| 国产精品秋霞免费鲁丝片| 午夜福利在线在线| 美女脱内裤让男人舔精品视频| 性高湖久久久久久久久免费观看| 99国产精品免费福利视频| 国产精品国产av在线观看| 国产伦理片在线播放av一区| av免费观看日本| 国产精品av视频在线免费观看| 少妇人妻一区二区三区视频| 国产男女超爽视频在线观看| 久久精品国产a三级三级三级| 亚洲精品一区蜜桃| 青春草视频在线免费观看| av在线app专区| av在线app专区| 久久亚洲国产成人精品v| 美女主播在线视频| 亚洲av.av天堂| 亚洲成人中文字幕在线播放| 亚洲国产最新在线播放| 视频中文字幕在线观看| 欧美国产精品一级二级三级 | 日本欧美视频一区| 精品亚洲成a人片在线观看 | 国产精品麻豆人妻色哟哟久久| 成年av动漫网址| 久久久久国产网址| 日韩制服骚丝袜av| 插阴视频在线观看视频| 精品亚洲乱码少妇综合久久| 观看免费一级毛片| 天堂俺去俺来也www色官网| 午夜福利高清视频| 男人舔奶头视频| 丰满人妻一区二区三区视频av| 免费久久久久久久精品成人欧美视频 | 亚洲av成人精品一二三区| 国产精品爽爽va在线观看网站| 老司机影院成人| 成年免费大片在线观看| 久久精品国产亚洲av涩爱| 久久精品人妻少妇| 狂野欧美激情性xxxx在线观看| 美女高潮的动态| 男人添女人高潮全过程视频| 欧美日韩一区二区视频在线观看视频在线| 成人18禁高潮啪啪吃奶动态图 | 欧美精品一区二区免费开放| 国产综合精华液| 欧美高清性xxxxhd video| 岛国毛片在线播放| 高清日韩中文字幕在线| 国产成人aa在线观看| 精品视频人人做人人爽| 亚洲精品久久久久久婷婷小说| 啦啦啦中文免费视频观看日本| 热re99久久精品国产66热6| 少妇的逼水好多| 日韩伦理黄色片| 少妇裸体淫交视频免费看高清| 亚洲欧美日韩另类电影网站 | 男女啪啪激烈高潮av片| 少妇人妻 视频| 国产免费一区二区三区四区乱码| 成人一区二区视频在线观看| 日韩人妻高清精品专区| 一区二区三区四区激情视频| 精品亚洲成a人片在线观看 | 1000部很黄的大片| 免费高清在线观看视频在线观看| 嫩草影院新地址| tube8黄色片| 免费观看在线日韩| 国产一区亚洲一区在线观看| 欧美日韩亚洲高清精品| 亚洲成人av在线免费| 丰满乱子伦码专区| 啦啦啦啦在线视频资源| 夫妻性生交免费视频一级片| 偷拍熟女少妇极品色| 免费在线观看成人毛片| 99视频精品全部免费 在线| 精品午夜福利在线看| 色婷婷久久久亚洲欧美| 三级经典国产精品| 精品久久久久久久久av| 人妻系列 视频| 美女脱内裤让男人舔精品视频| 十分钟在线观看高清视频www | 日本-黄色视频高清免费观看| 夜夜看夜夜爽夜夜摸| 少妇丰满av| 亚洲av男天堂| 嫩草影院新地址| 久久国产亚洲av麻豆专区| 亚洲精品一二三| 国产成人午夜福利电影在线观看| 午夜视频国产福利| 欧美人与善性xxx| 国产精品国产三级专区第一集| 亚洲国产欧美在线一区| 国产深夜福利视频在线观看| 永久免费av网站大全| 免费久久久久久久精品成人欧美视频 | 久久久久精品性色| 久久av网站| 爱豆传媒免费全集在线观看| 男男h啪啪无遮挡| 亚洲av在线观看美女高潮| 蜜臀久久99精品久久宅男| 久久久久人妻精品一区果冻| a级毛色黄片| 你懂的网址亚洲精品在线观看| 成人国产av品久久久| 亚洲欧美中文字幕日韩二区| 国产精品人妻久久久久久| 伦理电影大哥的女人| 日韩强制内射视频| 欧美xxxx黑人xx丫x性爽| 国产成人aa在线观看| 亚洲国产av新网站| 丰满人妻一区二区三区视频av| 超碰av人人做人人爽久久| 成人影院久久| 国产精品嫩草影院av在线观看| 高清在线视频一区二区三区| 国产一区二区三区综合在线观看 | 一个人看的www免费观看视频| 国产精品久久久久久久电影| 婷婷色综合大香蕉| 国产男人的电影天堂91| 在线观看国产h片| av不卡在线播放| 免费黄色在线免费观看| 国产色婷婷99| 黑丝袜美女国产一区| 精品久久久久久久久亚洲| 舔av片在线| 91精品国产国语对白视频| 精品99又大又爽又粗少妇毛片| 一级爰片在线观看| 黄色日韩在线| av播播在线观看一区| 日韩三级伦理在线观看| 婷婷色综合www| 91精品国产九色| 国产精品麻豆人妻色哟哟久久| 老司机影院毛片| 久久久午夜欧美精品| 美女国产视频在线观看| 91精品伊人久久大香线蕉| 亚洲国产精品国产精品| 国产又色又爽无遮挡免| 肉色欧美久久久久久久蜜桃| 欧美三级亚洲精品| 久久久亚洲精品成人影院| 亚洲av男天堂| 久久 成人 亚洲| 亚洲成人手机| 性色av一级| 国产色爽女视频免费观看| 国产有黄有色有爽视频| 亚洲经典国产精华液单| 久久人妻熟女aⅴ| 国产黄色免费在线视频| 日韩av不卡免费在线播放| 免费不卡的大黄色大毛片视频在线观看| 国产亚洲午夜精品一区二区久久| 中文字幕免费在线视频6| 国产成人一区二区在线| 中文天堂在线官网| xxx大片免费视频| 99久久综合免费| 亚洲精品国产av蜜桃| 交换朋友夫妻互换小说| 伦理电影免费视频| 国产乱来视频区| 欧美老熟妇乱子伦牲交| 欧美精品一区二区免费开放| 国产高清有码在线观看视频| 狠狠精品人妻久久久久久综合| 插逼视频在线观看| 日本av手机在线免费观看| 直男gayav资源| 人人妻人人澡人人爽人人夜夜| a级毛片免费高清观看在线播放| 免费黄色在线免费观看| 日韩在线高清观看一区二区三区| 免费不卡的大黄色大毛片视频在线观看| 精品少妇久久久久久888优播| a级毛色黄片| 中文字幕人妻熟人妻熟丝袜美| 五月天丁香电影| 国产免费又黄又爽又色| 色网站视频免费| 精品人妻偷拍中文字幕| 菩萨蛮人人尽说江南好唐韦庄| 一级片'在线观看视频| 久久精品久久精品一区二区三区| 2021少妇久久久久久久久久久| 国产精品国产三级国产专区5o| 日韩成人伦理影院| 一区二区三区精品91| 中国国产av一级| 极品教师在线视频| 亚洲久久久国产精品| 91aial.com中文字幕在线观看| 精品久久久久久电影网| 欧美成人a在线观看| 六月丁香七月| 国产无遮挡羞羞视频在线观看| 91狼人影院| 国产午夜精品久久久久久一区二区三区| 男女国产视频网站| 国产精品99久久99久久久不卡 | 多毛熟女@视频| 在线免费观看不下载黄p国产| 国产色爽女视频免费观看| 成人亚洲精品一区在线观看 | 伊人久久精品亚洲午夜| 日韩av不卡免费在线播放| 美女国产视频在线观看| 天天躁日日操中文字幕| 又爽又黄a免费视频| 欧美精品一区二区免费开放| av卡一久久| 国产色婷婷99| 肉色欧美久久久久久久蜜桃| 卡戴珊不雅视频在线播放| 少妇精品久久久久久久| 99精国产麻豆久久婷婷| 国产精品免费大片| 女性被躁到高潮视频| 国产精品麻豆人妻色哟哟久久| 亚洲av二区三区四区| 亚洲伊人久久精品综合| 久久久久人妻精品一区果冻| 亚洲欧美中文字幕日韩二区| 欧美日本视频| 欧美精品一区二区大全| 夫妻午夜视频| 午夜福利影视在线免费观看| 国产乱来视频区| 国产成人a区在线观看| 99精国产麻豆久久婷婷| 亚洲美女黄色视频免费看| 97超视频在线观看视频| 一区二区三区乱码不卡18| 老熟女久久久| 在线播放无遮挡| 性高湖久久久久久久久免费观看| 男女免费视频国产| 99热网站在线观看| 美女xxoo啪啪120秒动态图| 免费黄色在线免费观看| 中文资源天堂在线| 自拍偷自拍亚洲精品老妇| 亚洲国产欧美人成| 国产淫片久久久久久久久| 亚洲精品中文字幕在线视频 | av在线播放精品| 亚洲综合精品二区| 美女视频免费永久观看网站| 涩涩av久久男人的天堂| 国产白丝娇喘喷水9色精品| 欧美三级亚洲精品| 免费不卡的大黄色大毛片视频在线观看| 99久久综合免费| 18禁动态无遮挡网站| 久久久欧美国产精品| 我的老师免费观看完整版| 久久久久久伊人网av| 毛片一级片免费看久久久久| 性色av一级| 蜜桃久久精品国产亚洲av| 久久热精品热| 男女边吃奶边做爰视频| 韩国高清视频一区二区三区| 少妇的逼水好多| 国产亚洲5aaaaa淫片| 国产黄片视频在线免费观看| 成年av动漫网址| 国产黄色免费在线视频| 观看美女的网站| 久久久久久久大尺度免费视频| 亚洲欧美日韩东京热| 亚洲欧美成人综合另类久久久| 乱系列少妇在线播放| 色5月婷婷丁香| 国产一区二区在线观看日韩| 卡戴珊不雅视频在线播放| 国产免费又黄又爽又色| 免费观看av网站的网址| 国产精品国产三级国产av玫瑰| 嫩草影院入口| 熟妇人妻不卡中文字幕| 久久人妻熟女aⅴ| 少妇裸体淫交视频免费看高清| 欧美日本视频| 色吧在线观看| 日韩一区二区三区影片| 欧美日韩综合久久久久久| 久久久精品94久久精品| 国产精品久久久久久精品电影小说 | 大片免费播放器 马上看| 国产午夜精品一二区理论片| 午夜激情久久久久久久| 亚洲国产色片| 国产av一区二区精品久久 | 中文字幕av成人在线电影| 99九九线精品视频在线观看视频| 特大巨黑吊av在线直播| 三级经典国产精品| 欧美日韩视频高清一区二区三区二| 国产v大片淫在线免费观看| 国产精品麻豆人妻色哟哟久久| 亚洲精品乱码久久久久久按摩| 欧美少妇被猛烈插入视频| 如何舔出高潮| 亚洲av日韩在线播放| 狂野欧美激情性xxxx在线观看| 国产精品伦人一区二区| 最近中文字幕2019免费版| 中文精品一卡2卡3卡4更新| 国产成人aa在线观看| 亚洲av中文字字幕乱码综合| 大话2 男鬼变身卡| 美女内射精品一级片tv| 欧美97在线视频| 亚洲一区二区三区欧美精品| 国产成人a∨麻豆精品| 日本欧美视频一区| 人人妻人人澡人人爽人人夜夜| 日韩人妻高清精品专区| www.色视频.com| 插阴视频在线观看视频| 精品一区二区三卡| 亚洲av欧美aⅴ国产| 午夜福利视频精品| 国产淫语在线视频| 日韩伦理黄色片| 一本一本综合久久| 在线亚洲精品国产二区图片欧美 | 久久久成人免费电影| 性色avwww在线观看| h视频一区二区三区| 久久久久精品久久久久真实原创| 亚洲精品456在线播放app| 你懂的网址亚洲精品在线观看| 少妇的逼好多水| 性色av一级| 黄色日韩在线| 啦啦啦在线观看免费高清www| 老师上课跳d突然被开到最大视频| 亚洲av男天堂| av卡一久久| 亚洲经典国产精华液单| 欧美zozozo另类| 精品少妇黑人巨大在线播放| av一本久久久久| 国产在线男女| 色哟哟·www| 亚洲精华国产精华液的使用体验| 国产精品爽爽va在线观看网站| 欧美97在线视频| 久久久国产一区二区| 成人美女网站在线观看视频| 国产精品秋霞免费鲁丝片| 免费黄网站久久成人精品| 国产成人免费观看mmmm| 中文字幕人妻熟人妻熟丝袜美| www.色视频.com| 最近最新中文字幕大全电影3| 亚洲国产欧美在线一区| 久久久a久久爽久久v久久| 中国三级夫妇交换| 乱码一卡2卡4卡精品| 久久精品国产自在天天线| 国产一级毛片在线| 蜜臀久久99精品久久宅男| av国产久精品久网站免费入址| 18+在线观看网站| 少妇被粗大猛烈的视频| 亚洲精品中文字幕在线视频 | 日本黄色日本黄色录像| 最黄视频免费看| 毛片一级片免费看久久久久| 岛国毛片在线播放| 国产亚洲午夜精品一区二区久久| 极品教师在线视频| 肉色欧美久久久久久久蜜桃| 亚洲国产精品一区三区| 国产在线一区二区三区精| 日韩精品有码人妻一区| 在线 av 中文字幕| h日本视频在线播放| 亚洲婷婷狠狠爱综合网| 国产精品不卡视频一区二区| 亚洲国产精品专区欧美| 麻豆精品久久久久久蜜桃| 看十八女毛片水多多多| 亚洲欧洲日产国产| 欧美3d第一页| 成人亚洲欧美一区二区av| 国产成人免费无遮挡视频| 乱码一卡2卡4卡精品| 国产真实伦视频高清在线观看| 亚洲四区av| 中国美白少妇内射xxxbb| 丰满人妻一区二区三区视频av| 中文字幕亚洲精品专区| av网站免费在线观看视频| 综合色丁香网| 午夜免费男女啪啪视频观看| 精品一区二区免费观看| 亚洲精品中文字幕在线视频 | 我的老师免费观看完整版| 菩萨蛮人人尽说江南好唐韦庄| 校园人妻丝袜中文字幕| 国产乱人偷精品视频| 高清黄色对白视频在线免费看 | 国产91av在线免费观看| 国产黄色免费在线视频| 亚洲av电影在线观看一区二区三区| 国产一级毛片在线| 天堂中文最新版在线下载| 最近中文字幕高清免费大全6| 国产大屁股一区二区在线视频| 久久99蜜桃精品久久| 免费观看的影片在线观看| 久久这里有精品视频免费| 搡女人真爽免费视频火全软件| 久久久久国产精品人妻一区二区| 波野结衣二区三区在线| 欧美国产精品一级二级三级 | 亚洲精品国产成人久久av| 少妇高潮的动态图| 少妇 在线观看| 99久久中文字幕三级久久日本| 亚洲,欧美,日韩| 五月天丁香电影| 日韩精品有码人妻一区| kizo精华| 99久国产av精品国产电影| 深夜a级毛片| 成年女人在线观看亚洲视频| 91在线精品国自产拍蜜月| 韩国av在线不卡| 欧美bdsm另类| 日日啪夜夜爽| 在线观看一区二区三区| 国产精品国产三级国产专区5o| 亚洲天堂av无毛| 国产无遮挡羞羞视频在线观看| 99精国产麻豆久久婷婷| 嘟嘟电影网在线观看| 三级经典国产精品| 日本爱情动作片www.在线观看| 亚洲色图综合在线观看| 干丝袜人妻中文字幕| 男女免费视频国产| 国产成人免费无遮挡视频| 国产毛片在线视频| 丰满乱子伦码专区| 欧美97在线视频| 丰满人妻一区二区三区视频av| 成年av动漫网址| 亚洲精品日韩av片在线观看| 丰满少妇做爰视频| 人妻 亚洲 视频| 久久精品久久精品一区二区三区| 日日摸夜夜添夜夜添av毛片| 色哟哟·www|